190 related articles for article (PubMed ID: 16797755)
1. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.
Girinsky T; van der Maazen R; Specht L; Aleman B; Poortmans P; Lievens Y; Meijnders P; Ghalibafian M; Meerwaldt J; Noordijk E
Radiother Oncol; 2006 Jun; 79(3):270-7. PubMed ID: 16797755
[TBL] [Abstract][Full Text] [Related]
2. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
[TBL] [Abstract][Full Text] [Related]
3. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
Girinsky T; Specht L; Ghalibafian M; Edeline V; Bonniaud G; Van Der Maazen R; Aleman B; Paumier A; Meijnders P; Lievens Y; Noordijk E; Poortmans P;
Radiother Oncol; 2008 Aug; 88(2):202-10. PubMed ID: 18555548
[TBL] [Abstract][Full Text] [Related]
4. Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy.
Mulvihill DJ; McMichael K; Goyal S; Drachtman R; Weiss A; Khan AJ
Radiother Oncol; 2014 Aug; 112(2):279-83. PubMed ID: 25082095
[TBL] [Abstract][Full Text] [Related]
5. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
6. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
[TBL] [Abstract][Full Text] [Related]
7. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
[TBL] [Abstract][Full Text] [Related]
8. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).
Eich HT; Müller RP; Engenhart-Cabillic R; Lukas P; Schmidberger H; Staar S; Willich N;
Strahlenther Onkol; 2008 Aug; 184(8):406-10. PubMed ID: 18956517
[TBL] [Abstract][Full Text] [Related]
9. Importance of PET/CT scan use in planning radiation therapy for lymphoma.
Milana MA; Marko E; Miroslav L; Tihomir D
Asian Pac J Cancer Prev; 2015; 16(5):2051-4. PubMed ID: 25773849
[TBL] [Abstract][Full Text] [Related]
10. Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?
Lohr F; Georg D; Cozzi L; Eich HT; Weber DC; Koeck J; Knäusl B; Dieckmann K; Abo-Madyan Y; Fiandra C; Mueller RP; Engert A; Ricardi U
Strahlenther Onkol; 2014 Oct; 190(10):864-6, 868-71. PubMed ID: 25209551
[TBL] [Abstract][Full Text] [Related]
11. Multimodality imaging using PET/CT (
Édeline V; Remouchamps V; Isnardi V; Vander Borght T
Cancer Radiother; 2018 Sep; 22(5):384-392. PubMed ID: 30055933
[TBL] [Abstract][Full Text] [Related]
12. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.
Maraldo MV; Aznar MC; Vogelius IR; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1057-65. PubMed ID: 23200817
[TBL] [Abstract][Full Text] [Related]
13. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
Girinsky T; Ghalibafian M; Bonniaud G; Bayla A; Magne N; Ferreira I; Lumbroso J
Radiother Oncol; 2007 Nov; 85(2):178-86. PubMed ID: 17719110
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
15. Involved-node radiotherapy to the mediastinum.
Senan S; Piet A; Lagerwaard F
Radiother Oncol; 2007 Jan; 82(1):108-9; author reply 109-10. PubMed ID: 17125861
[No Abstract] [Full Text] [Related]
16. Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
Nielsen K; Maraldo MV; Berthelsen AK; Loft A; de Nully Brown P; Vogelius IR; Petersen PM; Specht L
Radiother Oncol; 2020 Sep; 150():236-244. PubMed ID: 32622782
[TBL] [Abstract][Full Text] [Related]
17. The significance of a uniform definition of pathological lymph nodes in Hodgkin lymphoma: impact of different thresholds for positive lymph nodes in CT imaging on staging and therapy.
Vorwerk H; Obenauer S; Schmidberger H; Hess CF; Weiss E
Radiother Oncol; 2008 Apr; 87(1):74-81. PubMed ID: 18061693
[TBL] [Abstract][Full Text] [Related]
18. [Intensity-modulated radiotherapy and involved-node concept in patients with Hodgkin lymphoma: experience of the Gustave-Roussy Institute].
Paumier A; Khodari W; Beaudre A; Ghalibafian M; Blanchard P; Al Hamokles H; Bhari M; Lessard N; Girinsky T
Cancer Radiother; 2011 Dec; 15(8):709-15. PubMed ID: 22116023
[TBL] [Abstract][Full Text] [Related]
19. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
20. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma.
Verhappen MH; Poortmans PM; Raaijmakers E; Raemaekers JM
Radiother Oncol; 2013 Oct; 109(1):133-9. PubMed ID: 24021344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]